2IN GROWTH MEDIUM
2IN GROWTH MEDIUM
ARACHIDONIC ACID
ARACHIDONIC ACID
ARACHIDONIC ACID
ARACHIDONIC ACID
ARACHIDONIC ACID
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE
AA RELEASE ASSAYS SHOW
AA RELEASE REDUCTION
ATCC
ATCC
ATCC
ATP
ATP
ATP
ATP
ATP
ATP
ATP
ATP
ATP
ATP
ATP
ATP
ATP
ATP
ATP
ACTIVATION
P38 ACTIVATION
ADOBE PHOTOSHOP
AGONIST-INDUCED AA RELEASE
BSA
BSA
BACKGROUND CYTOSOLIC PLA
BLEACH VALUE
ECFP BLEACH VALUE
C2 DOMAIN
C2 DOMAIN
CFP
CFP
CHO CELL
CHO CELL
CHO CELL
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CALBIOCHEM
CALCIUM IMAGING MDCK CELL
CELL CULTURE MDCK CELL
CERTAIN PROSTAGLANDIN
CHROMA
CHROMA
CLONTECH
CYTOSOLIC PLA
DJF
DMEM
DMEM
DMSO
DNA
DIFFERENT FLUORESCENT-PROTEIN
DUAL IMAGING MICROSCOPY
ECFP
ECFP
ECFP
ECFP
ECFP
ECFP-CPLA
ECFP-CPLA
ECFP-CPLA
ECFP-CPLA
ECFP-CPLA
ECFP-CPLA
ECFP/EYFP FLUORESCENCE CHANGE
EGFP
EGFP-CPLA
EGFP-CPLA
EGFP-CPLA
EGFP-POSITIVE CELL
EGFP-TAGGED
EGFP-TAGGED CPLA
ENDOPLASMIC RETICULUM
ENDOPLASMIC RETICULUM
ENDOPLASMIC RETICULUM
EXTRACELLULAR SIGNAL REGULATED KINASE
EXTRACELLULAR SIGNAL REGULATED KINASE
EXTRACELLULAR SIGNAL REGULATED KINASE
EXTRACELLULAR SIGNAL REGULATED KINASE
EXTRACELLULAR SIGNAL REGULATED KINASE
EXTRACELLULAR SIGNAL REGULATED KINASE
ERK ACTIVATION
ERK ACTIVATION
ERK ACTIVATION
ERK ACTIVATION
ERK ACTIVATION
ERK ACTIVATION
ERK ACTIVATION
ERK ACTIVATION
ERK ACTIVATION
ERK ACTIVATION
ERK ACTIVATION
ERK ACTIVITY
ERK ACTIVITY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PATHWAY
ERK PHOSPHORYLATION
SIGNALING CASCADE EXTRACELLULAR SIGNAL REGULATED KINASE
ERK
ERK
ERK
ERK
ERK
ERK
PHOSPHORYLATE CPLA ERK
EYFP
EYFP
EYFP
EYFP FLUORESCENCE
EYFP FLUORESCENCE
EYFP-CPLA
EYFP-CPLA
EYFP-CPLA
EYFP-CPLA
EYFP-CPLA
EYFP-CPLA
EYFP-CPLA
EYFP-CPLA
EYFP-CPLA
EXCITATION LIGHT
F T
FETAL           BOVINE SERUM
FP IMAGING STUDY
FINAL IMAGE
FUGENE-6
FURA2 DICHROIC MIRROR
FURA2 FLUORESCENCE
FURA2 IMAGE PAIR
FURA2-AM
GENETICIN
GOLGI
GOLGI
GOLGI
GOLGI
GOLGI
GOLGI
GOLGI
GOLGI
GOLGI
GOLGI
GOLGI MEMBRANE
HHBS
HHBS
HHBS
HHBS
HHBSS SUPPLEMENTED
HIRABAYASHI
HZ
IONO
IONO
IONO
IONO
IONO
IONO
IONO
IONO
IONO
IONO ACT
IONO STIMULATION
IONO-INDUCED AA RELEASE
IONO-STIMULATED AA RELEASE PEAK
IP
IMAGING EXPERIMENT
IMAGO CCD
IMMUNOBLOTTING STABLE EGFP-CPLA
IN VITRO STUDY
LAEMMLI ELECTROPHORESIS SAMPLE BUFFER
LYSATE
MAP KINASE
MAPK HOMOLOG P38
MADIN DARBY CANINE KIDNEY
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK CELL
MDCK-D
MDCK-D
MDCK-D
MEK
MEK
MEK
MEK INHIBITION
MEK INHIBITION
MEK INHIBITION
MEK INHIBITION
MEK INHIBITOR
MEK INHIBITOR
MEK INHIBITOR
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1
MEK1 INHIBITION
MEK1 INHIBITION
MEK1 INHIBITION
MEK1 INHIBITION
MEK1 INHIBITION
MEK1 INHIBITION
MEK1 INHIBITOR
MNKI
MADIN-DARBY CANINE KIDNEY
MATTEK
MATTEK PLATE
MATTEK PLATE
NA OIL IMMERSION OBJECTIVE
NA OIL IMMERSION OBJECTIVE
NHEI/BSRGI FRAGMENT
OLYMPUS SYSTEM
P 2Y2 RECEPTOR
PAF STIMULATION
PAUL INSEL
PHOSPHORYLATION
PHOSPHORYLATION
PHOSPHORYLATION
PHOSPHORYLATION
CPLA PHOSPHORYLATION
PHOTONIC
PHOTONIC
POLYCHROME IV
MONOCHROMATOR POLYCHROME IV
PROTEIN KINASE PATHWAY
PLAY MAJOR ROLE PROTEIN KINASE PATHWAY
RESULTS EFFECT
MEK INHIBITION RESULTS EFFECT
SDS-PAGE
SDS-POLYACRYLAMIDE GEL ELECTROPHORESI
SF9 CELL
SINGLE-CELL IMAGING
SUBCONFLUENT CELL
SUTTER FILTER WHEEL
TILLVISION SOFTWARE
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
CPLA TRANSLOCATION
PHOSPHORYLATION SITE MUTANT TRANSLOCATION
TRITON X-100
TRITON X-100
U/ML PENICILLIN
U/ML PENICILLIN
UCSD
XBAI/PSTI FRAGMENT
XBAI/PSTI SITE
YFP
YFP
ABILITY
ABILITY
CPLA ABILITY
ABSENCE
ABSENCE
ANISOMYCIN ABSENCE
ACTIVATED PROTEIN
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
P42 ACTIVATION
MEK1 ACTIVATION
ADDITION
ADRENERGIC RECEPTOR EXPRESSION
AFFECTED CPLA
AGENT
AGONIST
AGONIST
AGONIST
AMPLITUDE
ANALYZING GEL SHIFT
CPLA ANALYZING GEL SHIFT
ANISOMYCIN
ANISOMYCIN
ANISOMYCIN
ANISOMYCIN
ANISOMYCIN
ANISOMYCIN TREATMENT
ANISOMYCIN TREATMENT
ANISOMYCIN-STIMULATED P38 PHOSPHORYLATION
ANISOMYCIN-TREATED MACROPHAGE
ANTI-PHOSPHO-ERK ANTIBODY
ANTI-PHOSPHO-ERK IMMUNOBLOT
ANTI-PHOSPHO-P38 ANTIBODY
ANTIBIOTIC G418-SULFATE
ARACHIDONIC ACID
BICINCHONINIC ACID METHOD
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CPLA
CALCIUM INDICATOR FURA2
CALCIUM IONOPHORE
CALCIUM-DEPENDENT LIPID
CALCIUM-DEPENDENT LIPID-BINDING
CATALYTIC ACTIVITY
CATALYTIC ACTIVITY
CELL-TO-CELL HETEROGENEITY
CELLULAR LOCALIZATION
CHARACTERISTIC ELECTROPHORETIC MOBILITY SHIFT
CO-TRANSFECTED
COMPARE TRANSLOCATION
CONCENTRATION
CONFORMATION
CONSTITUTIVE ACTIVATION
ERK CONSTITUTIVE ACTIVATION
CONTAINING ENDOGENOUS CPLA
CONTRIBUTION
CONTROL CELL
CONTROL EXPERIMENT
CONTROLLING LEVEL
ARACHIDONIC ACID CONTROLLING LEVEL
COORDINATION
COORDINATION
COORDINATION
CRITICAL REGULATORY STEP
CULTURING
DE-ESTERIFICATION
DECREASED ERK ACTIVATION
DEMONSTRATED TRANSLOCATION
CPLA DEMONSTRATED TRANSLOCATION
DENSITY ERK
DETERMINING AA RELEASE
DISTRIBUTION
DISTRIBUTION
EYFP-CPLA DISTRIBUTION
EYFP-CPLA DISTRIBUTION
DOSE IONOPHORE
DOSE-DEPENDENT DECREASE
DOSE-DEPENDENTLY CATALYZES RELEASE
ARACHIDONIC ACID DOSE-DEPENDENTLY CATALYZES RELEASE
DUAL CFP/YFP DICHROIC MIRROR
DUAL CFP/YFP IMAGING APPROACH
DUAL EYFP/ECFP
ELECTROPHORETIC MOBILITY
EMISSION FILTER
ENDOGENOUS CPLA
ENDOGENOUS CPLA
ENDOGENOUS ENZYME
ENDOPLASMIC RETICULUM
ENZYME
ENZYME
ENZYME
ENZYME
EXPRESSING EGFP FLUORESCENCE
EXPRESSING EGFP-CPLA
EXPRESSING EGFP-CPLA
EXPRESSING EGFP-CPLA
EXPRESSING WILD-TYPE CPLA
EXPRESSING WILD-TYPE CPLA
EXTENSIVE EYFP-CPLA
EXTENSIVE TRANSLOCATION
EXTRACELLULAR ATP ACT
EXTRACELLULAR-SIGNAL
REGULATED KINASE EXTRACELLULAR-SIGNAL
FINAL MANUSCRIPT
FRACTION
FRACTION
CPLA FRACTION
TOTAL CELL FLUORESCENCE FRACTION
GEL
GEL SHIFT
GEL SHIFT
GEL SHIFT
GEL SHIFT
GEL SHIFT
GEL SHIFT
GEL SHIFT
GEL SHIFT CHARACTERISTIC
ENDOGENOUS CPLA GEL SHIFT CHARACTERISTIC
CPLA GEL SHIFT
GLYCEROL
GROWTH MEDIUM
GROWTH MEDIUM
GROWTH MEDIUM
GROWTH MEDIUM
GROWTH MEDIUM SUPPLEMENTED
HETEROGENEITY
HIGH-DOSE
HYDROLYTIC ACTIVITY
HYDROLYZE AA
HYDROLYZ
SN-2 ARACHIDONATE HYDROLYZ
ICE-COLD
LYSIS BUFFER ICE-COLD
IINCREASE
IMAGING STUDY
IMMORTALIZED MOUSE LUNG FIBROBLAST
IMMUNOBLOT ANALYSIS
IMMUNOBLOT
IMMUNOBLOTTING
IMMUNOBLOTTING
IN VITRO MODEL
INCLUDING P42
INCLUDING PROSTAGLANDIN
INCREASED P38 PHOSPHORYLATION
INCREASING CONCENTRATION
INFLAMMATORY RESPONSE
INHIBITED AA RELEASE
INHIBITED ATP
INHIBITED DOSE-DEPENDENTLY
INHIBITORY EFFECT
INTEREST CORRESPONDING
INTRACELLULAR CA
INTRACELLULAR MEMBRANE
INTRACELLULAR TARGETING
INTRACELLULAR TARGETING
INVERTED MICROSCOPE
INVESTIGATING MECHANISM
AA RELEASE INVESTIGATING MECHANISM
IONOMYCIN
IONOMYCIN TREATMENT
IONOPHORE
IONOPHORE
IONOPHORE
IONOPHORE STIMULATION
KINASE
KINAS
LACK ENDOGENOUS CPLA
LEUKOTRIENE
LIPID ASSOCIATION
LIPID MEDIATOR
INCLUDING PROSTAGLANDIN LIPID MEDIATOR
LIPID METABOLITES PLAY
LIVING CELL
LOW-DOSE
LOW-DOSE IONOPHORE
LYSATE
LYSIS BUFFER
MM EGTA
MM HEPE
MM HEPE
PH MM HEPE
MM MAGNESIUM CHLORIDE
MM PROBENECID
MM PROBENECID
MM PROBENECID
MM SODIUM CHLORIDE
MM SODIUM FLUORIDE
MACROPHAGE
MANUFACTURER
MEASURE CPLA
MEDIATED AA RELEASE
MEDIATED AA RELEASE
MEDIATED AA RELEASE
MEDIATED AA RELEASE INDEPENDENT
MEMBRANE PHOSPHOLIPID
MEMBRANE PROPERTY
MEMBRANE-PHOSPHOLIPID SUBSTRATE
MG/ML GENETICIN
MG/ML GENETICIN
MG/ML GLUTAMINE
MG/ML GLUTAMINE
MIN
MIN
MIN
MIN
MIN
MIN
MIN INCUBATION
MIN INCUBATION
DE-ESTERIFICATION MIN INCUBATION
FURA2-AM DE-ESTERIFICATION MIN INCUBATION
MIN POST-STIMULATION
MIN PRIOR
MIN TREATMENT
MITOGEN
ACTIVATED PROTEIN MITOGEN
MITOGEN-ACTIVATED PROTEIN KINASE KINASE
MOBILIZATION
MOBILIZATION
MOBILIZATION
MOBILIZATION
MOBILIZATION
MOBILIZATION
MOBILIZATION
MOLECULAR WEIGHT
EGFP-TAGGED CPLA MOLECULAR WEIGHT
MONOCHROMATOR
NG/ML ANISOMYCIN
NM
NM
NM
NON-MEMBRANE
OBSERVATION
OBSERVATION
OPTIMAL HYDROLYTIC ACTIVITY
OPTIMAL HYDROLYTIC ACTIVITY
OPTIMUM
HYDROLYTIC ACTIVITY OPTIMUM
OVER-EXPRESS
P38
P38
P38
P38
P38
P42
P44 ERK
P44 ERK
PECFP-CPLA
PECFP-CPLA
PEGFP-CPLA
PEGFP-CPLA
PEGFP-CPLA
PH
PERMEABILIZING CELL MEMBRANE
PHENOTYPE
PHENOTYPE
PHORBOL ESTER
PHOSPHO-SPECIFIC ANTIBODY
PHOSPHO-SPECIFIC ANTIBODY
EXTRACELLULAR SIGNAL REGULATED KINASE PHOSPHO-SPECIFIC ANTIBODY
PHOSPHOLIPID
PHOSPHOLIPID HYDROLYSI
PHOSPHORYLATE CPLA
PHOSPHORYLATION
PHOSPHORYLATION
PHOSPHORYLATION
PHOSPHORYLATION
PHOSPHORYLATION
PHOSPHORYLATION
PHOSPHORYLATION
PHOSPHORYLATION
PHOSPHORYLATION
PHOSPHORYLATION
REGULATORY PROTEIN PHOSPHORYLATION
P38 PHOSPHORYLATION
PHOSPHORYLATION SITE MUTANT
PHYSIOLOGICAL AGONIST
PHYSIOLOGICAL AGONIST
PHYSIOLOGICAL AGONIST
PHYSIOLOGICAL AGONIST
PHYSIOLOGICAL AGONIST
PHYSIOLOGICAL PROCESS
PLASMID
PLASMID
PLAY MAJOR ROLE
POLYCLONAL ANTIBODY
PRETREATMENT
PREVENTING TRANSLOCATION
CPLA PREVENTING TRANSLOCATION
PROTEIN CONCENTRATION
SUPERNATANT PROTEIN CONCENTRATION
PROTEIN TRANSLOCATION
QUANTITATIVE EFFECT
QUIESCED MDCK CELL
QUIESCED MDCK CELL
QUIESCED OVERNIGHT
QUIESCED OVERNIGHT
RAPID TRANSLOCATION
EYFP-CPLA RAPID TRANSLOCATION
RECEPTOR STIMULATION
REDUCING AA RELEASE
REGULATED KINASE
REGULATED STEP
REGULATING AA RELEASE INDEPENDENT
REGULATING CPLA
REGULATING CPLA
REGULATING CPLA
REGULATING TRANSLOCATION
REGULATORY PROTEIN
RELEASE AA
RESTING DISTRIBUTION
EYFP-CPLA RESTING DISTRIBUTION
S. FLUORESCENCE
SALT SOLUTION
SCINTILLATION COUNTING
SEQUENCING
SERUM-FREE MEDIUM
SERUM-FREE MEDIUM
SERUM-FREE MEDIUM
SERUM-FREE MEDIUM
SERUM-FREE MEDIUM
SERUM-FREE MEDIUM
SERUM-FREE MEDIUM
SIDE-BY-SIDE COMPARISON
MDCK CELL SIDE-BY-SIDE COMPARISON
SIGNALING CASCADE
SIGNALING PATHWAY
SINGLE-CELL FLUORESCENCE MICROSCOPY
SN-2 ARACHIDONATE
STUDIES SHOW
EXTENSIVE TRANSLOCATION STUDIES SHOW
SUBCLONE
SUBCLONE
MADIN DARBY CANINE KIDNEY SUBCLONE
SUPERNATANT
SUPERNATANT
SUPRAPHYSIOLOGICAL
SUPRAPHYSIOLOGICAL
SUSTAINED INCREASE SUPRAPHYSIOLOGICAL
SUSTAINED INCREASE
TEMPORAL CORRELATION
TEMPORALLY CORRELATED
TETRASODIUM PYROPHOSPHATE
TIME POINT
TOTAL AMOUNT
ARACHIDONIC ACID TOTAL AMOUNT
TOTAL CELL FLUORESCENCE
TOTAL CELLULAR RADIOACTIVITY
TRANSFECTANT
TRANSFECTED
TRANSFECTED
TRANSFECTED
TRANSFECTED MDCK CELL
TRANSFECTED CELL
TRANSFECTED CELL
TRANSLOCATE
TRANSLOCATE
TRANSLOCATE
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION KINETICS
TRANSLOCATION KINETICS
TRANSLOCATION KINETICS
EYFP-CPLA TRANSLOCATION
CPLA TRANSLOCATION
CPLA TRANSLOCATION
CPLA TRANSLOCATION
ENZYME TRANSLOCATION
TRANSLOCATION PROCESS
TRANSLOCATION RATE
TRANSLOCATION RATE
VECTOR PEGFP-C3
VEHICLE
VEHICLE
VENTRICULAR MYOCYTE
WILD-TYPE
WILD-TYPE CPLA
WILD-TYPE CPLA
WILD-TYPE CPLA
WK
ZINTEROL-INDUCED STIMULATION
ZINTEROL-MEDIATED AA RELEASE
Α-SPECIFIC INHIBITOR PYRROLIDINE-1
ΜCI
ΜM
ΜM
ΜM
ΜM
ΜM
ΜM
ΜM ATP
ΜM ATP
ΜM ATP
ΜM ATP
ΜM ATP
ΜM FURA2-AM
ΜM IONO
ΜM IONO
ΜM IONO
ΜM IONO
ΜM IONO
ΜM IONO
ΜM IONO
ΜM IONO
ΜM IONO
ΜM IONO
ΜM IONO
ΜM SODIUM VANADATE
ΜG
ΜG LYSATE PROTEIN
ΜG/ML APROTININ
ΜG/ML LEUPEPTIN
ΜG/ML STREPTOMYCIN
ΜG/ML STREPTOMYCIN
AA
CALCIUM-DEPENDENT LIPID         BINDING
CALB
EXTRACELLULAR-SIGNAL REGULATED KINASE
ERK
MITOGEN ACTIVATED         PROTEIN
MAP
MDCK
ER
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
RELEASE
AA RELEASE
RELEASE ASSAYS SHOW
ASSAYS SHOW
AA RELEASE
RELEASE REDUCTION
PHOTOSHOP
AA RELEASE
AA
CYTOSOLIC PLA
BLEACH
domains
domains
CALCIUM IMAGING MDCK
MDCK
CELL CULTURE MDCK
MDCK
PLA
EGFP-POSITIVE
EGFP-TAGGED
CPLA
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
ACTIVATION
pathways
pathways
pathways
pathways
pathways
pathways
pathways
pathways
pathways
pathways
pathways
pathways
pathways
pathways
PHOSPHORYLATION
LIGHT
T
DICHROIC MIRROR
FURA2
FURA2 IMAGE
FURA2
GOLGI
STIMULATION
AA RELEASE
AA
IONO-STIMULATED AA RELEASE
AA
IMMUNOBLOTTING
ELECTROPHORESIS SAMPLE BUFFER
sample buffer
KINASE
HOMOLOG P38
homolog
inhibition
inhibition
inhibition
inhibition
inhibitors
inhibitors
inhibition
inhibition
inhibition
inhibition
inhibition
inhibition
inhibitors
CANINE KIDNEY
OIL IMMERSION OBJECTIVE
IMMERSION OBJECTIVE
OIL IMMERSION OBJECTIVE
IMMERSION OBJECTIVE
2Y2
STIMULATION
INSEL
PROTEIN KINASE
KINASE
EFFECT
SF9
receptor expression
receptors
CPLA
GEL SHIFT
ANISOMYCIN
treatments
ANISOMYCIN
treatments
P38 PHOSPHORYLATION
P38
ANISOMYCIN-TREATED
ANTI-PHOSPHO-ERK
ANTI-PHOSPHO-ERK
INDICATOR FURA2
IONOPHORE
lipids
LIPID-BINDING
HETEROGENEITY
localization
ELECTROPHORETIC MOBILITY SHIFT
mobility shift
TRANSLOCATION
ACTIVATION
ENDOGENOUS CPLA
endogenous
controls
controls
regulatory step
ERK ACTIVATION
ERK
TRANSLOCATION
AA RELEASE
AA
IONOPHORE
decreases
CATALYZES RELEASE
CFP/YFP DICHROIC MIRROR
DICHROIC MIRROR
CFP/YFP
DUAL CFP/YFP
CFP/YFP IMAGING APPROACH
IMAGING APPROACH
CFP/YFP
EYFP/ECFP
emissions
filters
endogenous
CPLA
endogenous
CPLA
endogenous
reticulum
EXPRESSING EGFP
EGFP
WILD-TYPE CPLA
WILD-TYPE CPLA
TRANSLOCATION
EXTRACELLULAR ATP
extracellular
ATP
shifts
shifts
shifts
shifts
shifts
shifts
shifts
GEL SHIFT
growth
growth
growth
growth
growth
hydrolyze
AA
STUDIES
IMMUNOBLOT
analyses
P42
P38 PHOSPHORYLATION
P38
AA RELEASE
AA
ATP
EFFECT
interests
intracellular
CA
intracellular
IONOMYCIN
treatments
IONOPHORE
STIMULATION
ENDOGENOUS CPLA
endogenous
lipids
associations
lipids
lipids
METABOLITES PLAY
IONOPHORE
buffer
EGTA
PROBENECID
PROBENECID
PROBENECID
measures
CPLA
AA RELEASE
AA
AA RELEASE
AA
AA RELEASE
AA
MEDIATED AA RELEASE
AA
mg/ml
GENETICIN
mg/ml
GENETICIN
mg/ml
glutamine
mg/ml
glutamine
MIN
INCUBATION
MIN
INCUBATION
MIN
MIN
MIN
treatments
mitogen-activated protein kinase
PROTEIN KINASE KINASE
kinase kinases
KINASE
weights
ng/ml
ANISOMYCIN
ERK
P44
PHOSPHO-SPECIFIC
PHOSPHO-SPECIFIC
CPLA
PHOSPHORYLATION
AGONIST
AGONIST
AGONIST
plays
TRANSLOCATION
CONCENTRATION
TRANSLOCATION
EFFECT
QUIESCED MDCK
QUIESCED
MDCK
QUIESCED MDCK
QUIESCED
MDCK
TRANSLOCATION
receptors
STIMULATION
AA RELEASE
AA
KINASE
AA
CPLA
CPLA
CPLA
TRANSLOCATION
RELEASE
AA
DISTRIBUTION
solution
comparisons
pathways
ARACHIDONATE
STUDIES
shows
increases
correlations
PYROPHOSPHATE
times
TOTAL
total cells
CELLULAR RADIOACTIVITY
TRANSFECTED MDCK
TRANSFECTED
MDCK
TRANSFECTED
TRANSFECTED
TRANSLOCATION
TRANSLOCATION
TRANSLOCATION
CPLA
CPLA
CPLA
STIMULATION
AA RELEASE
AA
ΜM
ATP
ΜM
ATP
ΜM
ATP
ΜM
ATP
ΜM
ATP
FURA2-AM
ΜM
IONO
ΜM
IONO
ΜM
IONO
ΜM
IONO
ΜM
IONO
ΜM
IONO
ΜM
IONO
ΜM
IONO
ΜM
IONO
ΜM
IONO
ΜM
IONO
SODIUM VANADATE
LYSATE PROTEIN
μg/ml
aprotinin
μg/ml
leupeptin
μg/ml
μg/ml
